New Delhi. Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX)
(“Amneal” or the Company”), a global pharmaceutical company based in the U.S.,
today announced that it will build two new state-of-the-art manufacturing
facilities in Ahmedabad, expanding the Company’s longstanding presence and
innovation capabilities in India.
Founded
in 2002 by Chirag and Chintu Patel in New Jersey, Amneal is a global,
diversified pharmaceutical company that manufactures in the U.S., India and
Ireland. The Company established and has been growing its operations in India
since 2008, where it has eight manufacturing sites, including five in Ahmedabad
with additional sites in Dahej, Hyderabad and Vizag, and commercial offices in
Mumbai. The Company has the industry’s #1 quality track record and a diverse
and complex portfolio of more than 280 commercial products across Retail, Injectables,
Biosimilars and Specialty – all supported by its leading global R&D and
manufacturing capabilities.
In
this latest expansion in India, Amneal will make a total net investment of
between USD$150 million and $200 million over the next four to five years to
build two new greenfield facilities – one for peptide synthesis and one for
advanced sterile fill-finish manufacturing. Combined with Amneal’s existing
manufacturing network, the Company will develop and supply a portfolio of
next-generation branded medicines for metabolic diseases and obesity, including
GLP-1 and amylin receptor agonists, in collaboration with Metsera.
“Two
decades after our founding, Amneal has grown into one of the world’s most
innovative and trusted pharmaceutical companies that develops, manufactures and
supplies essential medicines. We have made meaningful strategic investments
over the years to bolster our world-class R&D capabilities, production
capacity and commercial infrastructure in India and globally. With these new
facilities, we are proud to be at the forefront of developing and manufacturing
innovative, branded medicines at scale in India, which will supply the local
market and the rest of the world,” said Chirag and Chintu Patel, Co-Founders
and Co-Chief Executive Officers.
dharmendra.bhaskar@mslgroup.com
0 Comments